Rosanna Fiallo-Scharer, MD
Professor, Pediatrics (Endocrinology); Program Director, Diabetes, Children's Wisconsin
- Children's Wisconsin
9000 W. Wisconsin Ave.
Milwaukee, WI 53226
Residency, Pediatrics, Monmouth Med Center, Long Beach, NJ, 1995
Fellowship, Pediatric Endocrinology, New York and Presbyterian Hospitals-Cornell Campus, 1998
Diabetes, adrenal disorders and disorders of sexual differentiation
The overall goal of my research is to improve the health and overall quality of life of those living with type 1 diabetes by identifying specific barriers to diabetes self-management in 6 distinct areas of self-care and tailoring interventions to each patient’s self- identified barriers.
Over the past 12 years I have been involved in collaborative research aimed at identifying genes and environmental factors involved in the determination of type 1 diabetes susceptibility and studying the applications of new technologies to improve clinical outcomes and quality of life in patients living with type 1 diabetes. During my almost 11 year appointment at the Barbara Davis Center for Diabetes and the University of Colorado Denver, I collaborated along with Dr. H Peter Chase with other diabetes researchers in academic centers across the country in conducting the first pediatric studies of Continuous Glucose Monitoring (CGM) technology applications in the pediatric population. My participation in the NIH-funded Diabetes Research in Children Network (DirecNet) consortium and the JDRF-funded Artificial Pancreas Project resulted in numerous publications including the first rigorously designed randomized controlled trial of CGM efficacy across a wide age spectrum (Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes. N Engl J Med 359;14 October 2, 2008). The study was powered to independently assess efficacy of CGM use for diabetes management in 3 distinct age groups: young children (8-14), adolescents and young adults (15-24) and older adults (>25). The study had a great impact in disseminating CGM use in clinical practices by facilitating insurance coverage of the technology.
Since I joined the faculty at MCW in November of 2012, I have been involved with the TrialNet Natural History study and the Type 1 diabetes exchange registry. The T1D exchange registry is maintaining a database of information obtained from a consortium of 67 clinical diabetes centers across the US. The rich dataset of the registry provides an opportunity to address numerous issues of relevance to clinicians and patients, including assessments of associations between patient characteristics and diabetes management factors with outcomes. Data recently published by the registry shows that less than 50% of patients of all ages are meeting the recommended goals for HbA1c and other parameters known to prevent long term complications. This highlights an urgent need to modify the chronic health care model in order to promote improved self-management. My main research focus for the next 3 years will be in a collaboration with researchers at UW Madison to implement a patient-centered approach to assigning diabetes management resources based on unique patient needs. This study is sponsored by a $2.1 million grant from the Patient Centered Outcomes Research Institute (PCORI).
(Singh A, Dasgupta M, Retherford D, Fiallo-Scharer R, Simpson PM, Panepinto JA.) Pediatr Diabetes. 2021 Mar;22(2):335-344 PMID: 33026680 SCOPUS ID: 2-s2.0-85092736732 10/08/2020
(Tosur M, Cleves MA, Sosenko JM, Libman I, Baidal DA, Balasubramanyam A, Redondo MJ, Type 1 Diabetes TrialNet Study Group.) J Clin Endocrinol Metab. 2020 12 01;105(12) PMID: 32502242 PMCID: PMC7531906 06/06/2020
(Wolfgram P, Zhang L, Simpson P, Fiallo-Scharer R.) Pediatr Diabetes. 2020 08;21(5):871-877 PMID: 32277561 SCOPUS ID: 2-s2.0-85083696981 04/12/2020
(Fiallo-Scharer R, Palta M, Chewning BA, Rajamanickam V, Wysocki T, Wetterneck TB, Cox ED.) Pediatr Diabetes. 2019 11;20(7):1016-1024 PMID: 31355957 PMCID: PMC6827338 SCOPUS ID: 2-s2.0-85070262007 07/30/2019
(Fiallo-Scharer R, Palta M, Chewning BA, Wysocki T, Wetterneck TB, Cox ED.) Contemp Clin Trials. 2017 07;58:58-65 PMID: 28450194 PMCID: PMC5535788 SCOPUS ID: 2-s2.0-85019122809 04/30/2017
(Onengut-Gumuscu S, Chen WM, Burren O, Cooper NJ, Quinlan AR, Mychaleckyj JC, Farber E, Bonnie JK, Szpak M, Schofield E, Achuthan P, Guo H, Fortune MD, Stevens H, Walker NM, Ward LD, Kundaje A, Kellis M, Daly MJ, Barrett JC, Cooper JD, Deloukas P, Type 1 Diabetes Genetics Consortium, Todd JA, Wallace C, Concannon P, Rich SS.) Nat Genet. 2015 Apr;47(4):381-6 PMID: 25751624 PMCID: PMC4380767 SCOPUS ID: 2-s2.0-84930408328 03/10/2015
(Beck RW, Tamborlane WV, Bergenstal RM, Miller KM, DuBose SN, Hall CA, T1D Exchange Clinic Network.) J Clin Endocrinol Metab. 2012 Dec;97(12):4383-9 PMID: 22996145 09/22/2012
(Ruedy KJ, Tamborlane WV, Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group.) J Cardiovasc Transl Res. 2012 Aug;5(4):380-7 PMID: 22538483 SCOPUS ID: 2-s2.0-84866114222 04/28/2012
(Hunt KA, Smyth DJ, Balschun T, Ban M, Mistry V, Ahmad T, Anand V, Barrett JC, Bhaw-Rosun L, Bockett NA, Brand OJ, Brouwer E, Concannon P, Cooper JD, Dias KR, van Diemen CC, Dubois PC, Edkins S, Fölster-Holst R, Fransen K, Glass DN, Heap GA, Hofmann S, Huizinga TW, Hunt S, Langford C, Lee J, Mansfield J, Marrosu MG, Mathew CG, Mein CA, Müller-Quernheim J, Nutland S, Onengut-Gumuscu S, Ouwehand W, Pearce K, Prescott NJ, Posthumus MD, Potter S, Rosati G, Sambrook J, Satsangi J, Schreiber S, Shtir C, Simmonds MJ, Sudman M, Thompson SD, Toes R, Trynka G, Vyse TJ, Walker NM, Weidinger S, Zhernakova A, Zoledziewska M, Type 1 Diabetes Genetics Consortium, UK Inflammatory Bowel Disease (IBD) Genetics Consortium, Wellcome Trust Case Control Consortium, Weersma RK, Gough SC, Sawcer S, Wijmenga C, Parkes M, Cucca F, Franke A, Deloukas P, Rich SS, Todd JA, van Heel DA.) Nat Genet. 2011 Dec 27;44(1):3-5 PMID: 22200769 PMCID: PMC3287292 SCOPUS ID: 2-s2.0-84555191729 12/28/2011
(Beck R, Steffes M, Xing D, Ruedy K, Mauras N, Wilson DM, Kollman C, Diabetes Research in Children Network (DirecNet) Study Group.) Pediatr Diabetes. 2011 Dec;12(8):690-5 PMID: 21496193 PMCID: PMC3193556 SCOPUS ID: 2-s2.0-82155183113 04/19/2011
(Lee JM, Rhee K, O'grady MJ, Basu A, Winn A, John P, Meltzer DO, Kollman C, Laffel LM, Lawrence JM, Tamborlane WV, Wysocki T, Xing D, Huang ES, JDRF Continuous Glucose Monitoring Study Group.) Med Care. 2011 Oct;49(10):924-31 PMID: 21544001 PMCID: PMC3210197 05/06/2011
(Xing D, Kollman C, Beck RW, Tamborlane WV, Laffel L, Buckingham BA, Wilson DM, Weinzimer S, Fiallo-Scharer R, Ruedy KJ, Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group.) Diabetes Technol Ther. 2011 Mar;13(3):351-8 PMID: 21299401 PMCID: PMC6468940 SCOPUS ID: 2-s2.0-79952173244 02/09/2011